On the medicinal chemistry of ferrocene
Identifieur interne : 001B22 ( Main/Exploration ); précédent : 001B21; suivant : 001B23On the medicinal chemistry of ferrocene
Auteurs : Mohammad F. R. Fouda [Égypte] ; Mokhles M. Abd-Elzaher [Égypte] ; Rafeek A. Abdelsamaia [Égypte] ; Ammar A. Labib [Égypte]Source :
- Applied Organometallic Chemistry [ 0268-2605 ] ; 2007-08.
English descriptors
- Teeft :
- Anticancer, Anticancer agents, Antimalarial, Antiproliferative, Antiproliferative effect, Antitumor, Appl, Bioorganometallic, Bioorganometallic chemistry, Biot, Breast cancer cells, Brocard, Cell line, Cell lines, Chem, Copyright, Cytotoxic, Cytotoxic effect, Derivative, Dyson, Electrochemical, Falciparum, Ferrocene, Ferrocene derivatives, Ferrocene moiety, Ferrocenyl, Ferrocenyl compounds, Ferrocenyl derivatives, Ferrocenyl moiety, Ferrocifens, Fouda, Hybridization, Important role, Inorg, Jaouen, John wiley sons, Maciejewski, Medicinal, Medicinal chemistry, Moiety, Neuse, Organomet, Organometal, Para, Plasmodium falciparum, Polym, Receptor, Redox, Redox properties, Tamoxifen, Topoisomerase, Vessieres, Weekly epidemiol.
Abstract
Organometallic chemistry and biochemistry have been merged in the last two decades into a new field: bioorganometallic chemistry. This new research area was devoted to the synthesis of new organometallic compounds and their biological and medical effects against some types of diseases, such as cancer and malaria. For several years, the use of ferrocene in bioorganometallic chemistry has been growing rapidly, and several promising applications have been developed since ferrocene is a stable, nontoxic compound and has good redox properties. This review will focus on ferrocenyl compounds which have been biologically evaluated against certain diseases. This area has attracted many researchers due to the promising results of some ferrocene compounds in the medicinal applications. Copyright © 2007 John Wiley & Sons, Ltd.
The use of ferrocene in bioorganometal‐lic chemistry has been growing rapidly, and several promising applications have been developed since ferrocene is a stable compound, nontoxic and has good redox properties. This review will focus on ferrocenyl compounds which have been biologically evaluated against certain diseases. This area has attracted many researchers due to the promising results of some ferrocene compounds in the medicinal applications.
Url:
DOI: 10.1002/aoc.1202
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000F25
- to stream Istex, to step Curation: 000F25
- to stream Istex, to step Checkpoint: 000A05
- to stream Main, to step Merge: 001B33
- to stream Main, to step Curation: 001B22
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">On the medicinal chemistry of ferrocene</title><author><name sortKey="Fouda, Mohammad F R" sort="Fouda, Mohammad F R" uniqKey="Fouda M" first="Mohammad F. R." last="Fouda">Mohammad F. R. Fouda</name></author><author><name sortKey="Abd Lzaher, Mokhles M" sort="Abd Lzaher, Mokhles M" uniqKey="Abd Lzaher M" first="Mokhles M." last="Abd-Elzaher">Mokhles M. Abd-Elzaher</name></author><author><name sortKey="Abdelsamaia, Rafeek A" sort="Abdelsamaia, Rafeek A" uniqKey="Abdelsamaia R" first="Rafeek A." last="Abdelsamaia">Rafeek A. Abdelsamaia</name></author><author><name sortKey="Labib, Ammar A" sort="Labib, Ammar A" uniqKey="Labib A" first="Ammar A." last="Labib">Ammar A. Labib</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:BB8F889A306378A472CEC2729866C81C1B141542</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1002/aoc.1202</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-2NR9FN8Z-8/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000F25</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F25</idno><idno type="wicri:Area/Istex/Curation">000F25</idno><idno type="wicri:Area/Istex/Checkpoint">000A05</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A05</idno><idno type="wicri:doubleKey">0268-2605:2007:Fouda M:on:the:medicinal</idno><idno type="wicri:Area/Main/Merge">001B33</idno><idno type="wicri:Area/Main/Curation">001B22</idno><idno type="wicri:Area/Main/Exploration">001B22</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">On the medicinal chemistry of ferrocene</title><author><name sortKey="Fouda, Mohammad F R" sort="Fouda, Mohammad F R" uniqKey="Fouda M" first="Mohammad F. R." last="Fouda">Mohammad F. R. Fouda</name><affiliation wicri:level="1"><country xml:lang="fr">Égypte</country><wicri:regionArea>Inorganic Chemistry Department, National Research Centre, PO 12622 Dokki, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation></author><author><name sortKey="Abd Lzaher, Mokhles M" sort="Abd Lzaher, Mokhles M" uniqKey="Abd Lzaher M" first="Mokhles M." last="Abd-Elzaher">Mokhles M. Abd-Elzaher</name><affiliation wicri:level="1"><country xml:lang="fr">Égypte</country><wicri:regionArea>Inorganic Chemistry Department, National Research Centre, PO 12622 Dokki, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation><affiliation></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Égypte</country><wicri:regionArea>Correspondence address: Inorganic Chemistry Department, National Research Centre, PO 12622 Dokki, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation></author><author><name sortKey="Abdelsamaia, Rafeek A" sort="Abdelsamaia, Rafeek A" uniqKey="Abdelsamaia R" first="Rafeek A." last="Abdelsamaia">Rafeek A. Abdelsamaia</name><affiliation wicri:level="1"><country xml:lang="fr">Égypte</country><wicri:regionArea>Inorganic Chemistry Department, National Research Centre, PO 12622 Dokki, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation></author><author><name sortKey="Labib, Ammar A" sort="Labib, Ammar A" uniqKey="Labib A" first="Ammar A." last="Labib">Ammar A. Labib</name><affiliation wicri:level="1"><country xml:lang="fr">Égypte</country><wicri:regionArea>Inorganic Chemistry Department, National Research Centre, PO 12622 Dokki, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Applied Organometallic Chemistry</title><title level="j" type="alt">APPLIED ORGANOMETALLIC CHEMISTRY</title><idno type="ISSN">0268-2605</idno><idno type="eISSN">1099-0739</idno><imprint><biblScope unit="vol">21</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="613">613</biblScope><biblScope unit="page" to="625">625</biblScope><biblScope unit="page-count">13</biblScope><publisher>John Wiley & Sons, Ltd.</publisher><pubPlace>Chichester, UK</pubPlace><date type="published" when="2007-08">2007-08</date></imprint><idno type="ISSN">0268-2605</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0268-2605</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Anticancer</term><term>Anticancer agents</term><term>Antimalarial</term><term>Antiproliferative</term><term>Antiproliferative effect</term><term>Antitumor</term><term>Appl</term><term>Bioorganometallic</term><term>Bioorganometallic chemistry</term><term>Biot</term><term>Breast cancer cells</term><term>Brocard</term><term>Cell line</term><term>Cell lines</term><term>Chem</term><term>Copyright</term><term>Cytotoxic</term><term>Cytotoxic effect</term><term>Derivative</term><term>Dyson</term><term>Electrochemical</term><term>Falciparum</term><term>Ferrocene</term><term>Ferrocene derivatives</term><term>Ferrocene moiety</term><term>Ferrocenyl</term><term>Ferrocenyl compounds</term><term>Ferrocenyl derivatives</term><term>Ferrocenyl moiety</term><term>Ferrocifens</term><term>Fouda</term><term>Hybridization</term><term>Important role</term><term>Inorg</term><term>Jaouen</term><term>John wiley sons</term><term>Maciejewski</term><term>Medicinal</term><term>Medicinal chemistry</term><term>Moiety</term><term>Neuse</term><term>Organomet</term><term>Organometal</term><term>Para</term><term>Plasmodium falciparum</term><term>Polym</term><term>Receptor</term><term>Redox</term><term>Redox properties</term><term>Tamoxifen</term><term>Topoisomerase</term><term>Vessieres</term><term>Weekly epidemiol</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Organometallic chemistry and biochemistry have been merged in the last two decades into a new field: bioorganometallic chemistry. This new research area was devoted to the synthesis of new organometallic compounds and their biological and medical effects against some types of diseases, such as cancer and malaria. For several years, the use of ferrocene in bioorganometallic chemistry has been growing rapidly, and several promising applications have been developed since ferrocene is a stable, nontoxic compound and has good redox properties. This review will focus on ferrocenyl compounds which have been biologically evaluated against certain diseases. This area has attracted many researchers due to the promising results of some ferrocene compounds in the medicinal applications. Copyright © 2007 John Wiley & Sons, Ltd.</div><div type="abstract" xml:lang="en">The use of ferrocene in bioorganometal‐lic chemistry has been growing rapidly, and several promising applications have been developed since ferrocene is a stable compound, nontoxic and has good redox properties. This review will focus on ferrocenyl compounds which have been biologically evaluated against certain diseases. This area has attracted many researchers due to the promising results of some ferrocene compounds in the medicinal applications.</div></front></TEI><affiliations><list><country><li>Égypte</li></country></list><tree><country name="Égypte"><noRegion><name sortKey="Fouda, Mohammad F R" sort="Fouda, Mohammad F R" uniqKey="Fouda M" first="Mohammad F. R." last="Fouda">Mohammad F. R. Fouda</name></noRegion><name sortKey="Abd Lzaher, Mokhles M" sort="Abd Lzaher, Mokhles M" uniqKey="Abd Lzaher M" first="Mokhles M." last="Abd-Elzaher">Mokhles M. Abd-Elzaher</name><name sortKey="Abd Lzaher, Mokhles M" sort="Abd Lzaher, Mokhles M" uniqKey="Abd Lzaher M" first="Mokhles M." last="Abd-Elzaher">Mokhles M. Abd-Elzaher</name><name sortKey="Abdelsamaia, Rafeek A" sort="Abdelsamaia, Rafeek A" uniqKey="Abdelsamaia R" first="Rafeek A." last="Abdelsamaia">Rafeek A. Abdelsamaia</name><name sortKey="Labib, Ammar A" sort="Labib, Ammar A" uniqKey="Labib A" first="Ammar A." last="Labib">Ammar A. Labib</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B22 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B22 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:BB8F889A306378A472CEC2729866C81C1B141542
|texte= On the medicinal chemistry of ferrocene
}}
| This area was generated with Dilib version V0.6.33. |  |